Anti-Mllerian hormone (AMH) is a glycoprotein hormone produced by granulosa cells in ovarian follicles. Serum AMH levels are often used as an indicator of ovarian reserve, reflecting the quantity of remaining oocytes. Clinically, AMH measurements play a crucial role in assessing female fertility potential, particularly in the context of assisted reproductive technologies. Because diminished ovarian reserve is associated with lower AMH, efforts to understand factors impacting AMH are of importance to individuals planning conception.
Maintaining adequate AMH levels can be beneficial for women seeking pregnancy, as it suggests a greater likelihood of successful ovarian stimulation and oocyte retrieval during IVF procedures. Historically, understanding the determinants of AMH has been limited; however, research into lifestyle factors, supplementation, and medical interventions continues. A focus on optimizing AMH underscores the desire to enhance reproductive health and improve the chances of successful conception, particularly for women experiencing age-related decline in fertility or other conditions affecting ovarian reserve.
